Trial record 1 of 1 for: NovoCure EF-14
Previous Study | Return to List | Next Study
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
This study is currently recruiting participants.
Verified January 2014 by NovoCure Ltd.
Information provided by (Responsible Party):
First received: June 5, 2009
Last updated: February 5, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||April 2015|
|Estimated Primary Completion Date:||January 2015 (Final data collection date for primary outcome measure)|